Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid
Calling all clinicians, clinician-scientists and biomedical researchers to complete the 'State of Endocrinology 2025 Survey' - this is your chance to raise your voice!
Bioscientifica is delighted to announce that it has been selected as the new association management provider for the International Society of Endocrinology (ISE), effective January 2025. This appointment follows a competitive selection process led by the ISE Board.
Novo Nordisk's new obesity pill, amycretin, has shown promising results in early clinical trials, with participants losing up to 13% of their body weight in just 12 weeks, significantly outperforming placebo groups. The treatment may offer faster weight loss than Novo's popular Wegovy injection.
Clarivate, owner of Web of Science, the citation index of scientific and scholarly publishing, has published its 2023 Journal Impact Factors as part of its 2024 Journal Citation Reports. We are delighted to announce significant increases in Journal Impact Factors for Reproduction and Fertility and EFORT Open Reviews. Reproduction and Fertility, an official journal of the Society for Reproduction and Fertility (SRF) has achieved a 2023 figure of 2.8.
According to a study published in eBioMedicine, consuming sweeteners in place of sugar resulted in no difference in appetite or endocrine response in adults with obesity or high BMI, whilst insulin and blood sugar were reduced in sweetener use. Further research is necessary.
News Medical